General (n=71) | 99mTc-NC+MB (n=48) | 99mTc-NC+ICG (n=23) | p-value | |
Age (years) [mean (CI)] | 62.4 (59.6–65.2) | 63.2 (59.7–66.6) | 60.9 (56.0–65.8) | 0.455 |
Hx: Endometrioid | 63 (88.7%) | 42 (87.5%) | 21 (91.3%) | |
Hx: Serous carcinoma | 6 (8.5%) | 4 (8.3%) | 2 (8.7%) | |
Hx: Carcinosarcoma | 2 (2.8%) | 2 (4.2%) | 0 (0%) | 1.000 |
St: Stage I | 53 (74.6%) | 34 (70.8%) | 19 (82.6%) | |
St: Stage II | 10 (14.1%) | 7 (14.6%) | 3 (13.0%) | |
St: Stage III | 8 (11.2%) | 5 (10.5%) | 2 (2.8%) | 0.696 |
Route: Laparotomy | 3 (4.2%) | 3 (6.3%) | 0 (0%) | |
Route: Minimally invasive | 68 (95.8%) | 45 (93.7%) | 23 (100.0%) | 0.002 |